Deniz A. Uçar

1.1k total citations
26 papers, 835 citations indexed

About

Deniz A. Uçar is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Deniz A. Uçar has authored 26 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Deniz A. Uçar's work include Cancer Cells and Metastasis (7 papers), Cell Adhesion Molecules Research (5 papers) and Epigenetics and DNA Methylation (4 papers). Deniz A. Uçar is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Cell Adhesion Molecules Research (5 papers) and Epigenetics and DNA Methylation (4 papers). Deniz A. Uçar collaborates with scholars based in United States, Türkiye and Italy. Deniz A. Uçar's co-authors include Jan S. Moreb, Blanca Ostmark, Steven N. Hochwald, John K. Amory, Christopher R. Cogle, Shuhong Han, Alex Goldstein, Lung-Ji Chang, Edward W. Scott and James R. Zucali and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Deniz A. Uçar

23 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deniz A. Uçar United States 14 401 382 234 101 92 26 835
Houjie Liang China 19 459 1.1× 238 0.6× 215 0.9× 107 1.1× 115 1.3× 36 862
T Sethi United Kingdom 17 542 1.4× 422 1.1× 73 0.3× 93 0.9× 98 1.1× 37 1.1k
Evelyn Aranda United States 11 412 1.0× 210 0.5× 126 0.5× 68 0.7× 106 1.2× 12 753
Yan-Gao Man United States 15 525 1.3× 423 1.1× 278 1.2× 49 0.5× 159 1.7× 22 1.1k
Emy J. Chen United States 7 857 2.1× 302 0.8× 288 1.2× 179 1.8× 173 1.9× 7 1.4k
Joan Josep Bech‐Serra Spain 17 712 1.8× 368 1.0× 202 0.9× 36 0.4× 83 0.9× 34 1.1k
Luciana Rodrigues Gomes Brazil 13 457 1.1× 193 0.5× 237 1.0× 35 0.3× 61 0.7× 17 810
Gilda Raguénez France 18 614 1.5× 209 0.5× 150 0.6× 67 0.7× 135 1.5× 29 1.0k
Daniel T. Dransfield United States 18 780 1.9× 283 0.7× 223 1.0× 89 0.9× 139 1.5× 46 1.2k
Zhenyu Ji United States 15 901 2.2× 394 1.0× 138 0.6× 67 0.7× 111 1.2× 40 1.2k

Countries citing papers authored by Deniz A. Uçar

Since Specialization
Citations

This map shows the geographic impact of Deniz A. Uçar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deniz A. Uçar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deniz A. Uçar more than expected).

Fields of papers citing papers by Deniz A. Uçar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deniz A. Uçar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deniz A. Uçar. The network helps show where Deniz A. Uçar may publish in the future.

Co-authorship network of co-authors of Deniz A. Uçar

This figure shows the co-authorship network connecting the top 25 collaborators of Deniz A. Uçar. A scholar is included among the top collaborators of Deniz A. Uçar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deniz A. Uçar. Deniz A. Uçar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Zhi, Ameya S. Champhekar, Deniz A. Uçar, et al.. (2022). Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses. Frontiers in Immunology. 13. 987298–987298. 7 indexed citations
2.
Wright, Thomas D., Margarite D. Matossian, Deniz A. Uçar, et al.. (2021). Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer. Translational Oncology. 14(6). 101046–101046. 8 indexed citations
3.
Matossian, Margarite D., Steven Elliott, Hope E. Burks, et al.. (2021). Correction: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor. PLoS ONE. 16(4). e0251106–e0251106. 1 indexed citations
4.
Matossian, Margarite D., Steven Elliott, Hope E. Burks, et al.. (2020). Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor. PLoS ONE. 15(10). e0226464–e0226464. 13 indexed citations
5.
Hossain, Fokhrul, Samarpan Majumder, Deniz A. Uçar, et al.. (2018). Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses. Frontiers in Immunology. 9. 1288–1288. 41 indexed citations
6.
Hossain, Fokhrul, Claudia Sorrentino, Deniz A. Uçar, et al.. (2018). Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical Pathways. Frontiers in Oncology. 8. 575–575. 76 indexed citations
7.
Coşkun, Ali, et al.. (2015). Treatment of hypertriglyceridemia-induced acute pancreatitis with insulin. Gastroenterology Review. 1(1). 18–22. 51 indexed citations
8.
Kurenova, Elena, Deniz A. Uçar, Jianqun Liao, et al.. (2014). A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells. Cell Cycle. 13(16). 2542–2553. 13 indexed citations
9.
Uçar, Deniz A., Andrew T. Magis, Nicholas J. Lawrence, et al.. (2013). Inhibiting the Interaction of cMET and IGF-1R with FAK Effectively Reduces Growth of Pancreatic Cancer Cells in vitro and in vivo. Anti-Cancer Agents in Medicinal Chemistry. 13(4). 595–602. 25 indexed citations
10.
Uçar, Deniz A., Elena Kurenova, Timothy J. Garrett, et al.. (2012). Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth. Cell Cycle. 11(17). 3250–3259. 39 indexed citations
11.
Gu, Yumei, Sen Lin, Jian‐Liang Li, et al.. (2011). Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion. Oncogene. 31(4). 469–479. 69 indexed citations
12.
Uçar, Deniz A., et al.. (2011). A Novel Small Molecule Inhibitor of FAK and IGF-1R Protein Interactions Decreases Growth of Human Esophageal Carcinoma. Anti-Cancer Agents in Medicinal Chemistry. 11(7). 629–637. 9 indexed citations
13.
14.
Uçar, Deniz A., et al.. (2011). Abstract 3582: Targeting the FAK amino terminus F2 subdomain to disrupt growth factor receptor protein interactions, signaling and function. Cancer Research. 71(8_Supplement). 3582–3582. 1 indexed citations
15.
Uçar, Deniz A. & Steven N. Hochwald. (2010). FAK and Interacting Proteins as Therapeutic Targets in Pancreatic Cancer. Anti-Cancer Agents in Medicinal Chemistry. 10(10). 742–746. 14 indexed citations
16.
Zheng, Donghang, Elena Kurenova, Deniz A. Uçar, et al.. (2009). Targeting of the protein interaction site between FAK and IGF-1R. Biochemical and Biophysical Research Communications. 388(2). 301–305. 22 indexed citations
17.
Uçar, Deniz A., Christopher R. Cogle, James R. Zucali, et al.. (2008). Aldehyde dehydrogenase activity as a functional marker for lung cancer. Chemico-Biological Interactions. 178(1-3). 48–55. 138 indexed citations
18.
Martynyuk, Anatoly E., Deniz A. Uçar, Dawn Yang, et al.. (2007). Epilepsy in Phenylketonuria: A Complex Dependence on Serum Phenylalanine Levels. Epilepsia. 48(6). 1143–1150. 23 indexed citations
19.
Uçar, Deniz A., et al.. (1983). Circadian Variation in Circulating Pyrogen: Possible Role in Resistance to Infection. Experimental Biology and Medicine. 173(3). 319–323. 20 indexed citations
20.
Uçar, Deniz A., et al.. (1976). Chemical and biological characterization of an active substance of the human placenta. European Journal of Obstetrics & Gynecology and Reproductive Biology. 6(3). 109–114. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Houjie Liang Breakdown of academic impact, for papers by T Sethi Breakdown of academic impact, for papers by Evelyn Aranda Breakdown of academic impact, for papers by Yan-Gao Man Breakdown of academic impact, for papers by Emy J. Chen Breakdown of academic impact, for papers by Joan Josep Bech‐Serra Breakdown of academic impact, for papers by Luciana Rodrigues Gomes Breakdown of academic impact, for papers by Gilda Raguénez Breakdown of academic impact, for papers by Daniel T. Dransfield Breakdown of academic impact, for papers by Zhenyu Ji
Rankless by CCL
2026